Scribe Therapeutics
SCTX----
Scribe Therapeutics (SCTX)
Scribe Therapeutics Inc. is a clinical-stage biotechnology company, focuses on research and developing genetic medicines using CRISPR-based tools to address the...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
News
- PUBT · 3 hours ago
Scribe Therapeutics adopts amended and restated bylaws effective at IPO close
- Price Alert · 7 hours ago
U.S. stock market update: Scribe Therapeutics down 12.03%, stock price pressured by clinical delay in gene editing
- biopharmadive · 9 hours ago
Scribe secures $129M in a rare gene editing IPO
